Page 160 - 南京医科大学自然版

第46卷第6期
·942 · 南 京 医 科 大 学 学 报 2026年6月

［5］ PASKEH M D A，GHADYANI F，HASHEMI M，et al. Bio⁃ Cell Metab，2024，36（8）：1696-1710
logical impact and therapeutic perspective of targeting ［16］PETRELLA G，CORSI F，CIUFOLINI G，et al. Metabolic
PI3K/Akt signaling in hepatocellular carcinoma：promises reprogramming of castration ⁃ resistant prostate cancer
and challenges［J］. Pharmacol Res，2023，187：106553 cells as a response to chemotherapy［J］. Metabolites，
［6］ HANAHAN D，WEINBERG R A. Hallmarks of cancer： 2022，13（1）：65
the next generation［J］. Cell，2011，144（5）：646-674 ［17］YANG W，WANG Y，HUANG Y，et al. 4⁃octyl itaconate
［7］ SEMENZA G L. Hypoxia⁃inducible factors：coupling glu⁃ inhibits aerobic glycolysis by targeting GAPDH to pro⁃
cose metabolism and redox regulation with induction of mote cuproptosis in colorectal cancer［J］. Biomed Phar⁃
the breast cancer stem cell phenotype［J］. EMBO J，2017， macother，2023，159：114301
36（3）：252-259 ［18］XIE J，YANG Y，GAO Y，et al. Cuproptosis：mechanisms
［8］ CHEN J，HUANG Z，CHEN Y，et al. Lactate and lacty⁃ and links with cancers［J］. Mol Cancer，2023，22（1）：46
lation in cancer［J］. Signal Transduct Target Ther，2025， ［19］YANG H，DENG B，HAN X，et al. C5a/C5aR pathway
10（1）：38 blocking promoted CuS⁃mediated cancer therapy effect by
［9］ MONDAL S，ROY D，SARKAR BHATTACHARYA S，et inhibiting cuproptosis resistance［J］. J Immunother Can⁃
al. Therapeutic targeting of PFKFB3 with a novel glycolyt⁃ cer，2025，13（6）：e011472
ic inhibitor PFK158 promotes lipophagy and chemosensi⁃ ［20］HE R，HU C，YUAN Y，et al. Glycolysis reprogramming
tivity in gynecologic cancers［J］. Int J Cancer，2019，144 in CAFs promotes oxaliplatin resistance in pancreatic can⁃
（1）：178-189 cer through circABCC4 mediated PKM2 nuclear translo⁃
［10］刘进宇，段佳文，张志生. 从代谢与免疫视角解析乳腺 cation［J］. Cell Death Dis，2025，16（1）：126
癌肿瘤微环境：精准医学的挑战与机遇［J］. 南京医科 ［21］DING C，YI X，CHEN X，et al. Warburg effect⁃promoted
大学学报（自然科学版），2026，46（3）：343-354 exosomal circ_0072083 releasing up ⁃ regulates NANGO
LIU J Y，DUAN J W，ZHANG Z S. Deciphering the tumor expression through multiple pathways and enhances temo⁃
microenvironment of breast cancer from metabolic and im⁃ zolomide resistance in glioma［J］. J Exp Clin Cancer Res，
munological perspectives：challenges and opportunities in 2021，40（1）：164
precision medicine［J］. Journal of Nanjing Medical Uni⁃ ［22］HO K H，CHEN P H，CHOU C M，et al. A key role of
versity（Natural Sciences），2026，46（3）：343-354 DNA damage⁃inducible transcript 4（DDIT4）connects au⁃
［11］ALHARBI M，LAI A，SHARMA S，et al. Extracellular vesi⁃ tophagy and GLUT3⁃mediated stemness to desensitize te⁃
cle transmission of chemoresistance to ovarian cancer mozolomide efficacy in glioblastomas［J］. Neurotherapeu⁃
cells is associated with hypoxia⁃induced expression of gly⁃ tics，2020，17（3）：1212-1227
colytic pathway proteins，and prediction of epithelial ovar⁃ ［23］SHIGETA K，HASEGAWA M，HISHIKI T，et al. IDH2
ian cancer disease recurrence［J］. Cancers（Basel），2021， stabilizes HIF⁃1α⁃induced metabolic reprogramming and
13（14）：3388 promotes chemoresistance in urothelial cancer［J］. EMBO
［12］LIN J，XIA L，OYANG L，et al. The POU2F1⁃ALDOA axis J，2023，42（4）：e110620
promotes the proliferation and chemoresistance of colon ［24］WU Y，LU R，LIN Y，et al. DEHP mediates drug resis⁃
cancer cells by enhancing glycolysis and the pentose tance by metabolic reprogramming in colorectal cancer
phosphate pathway activity［J］. Oncogene，2022，41（7）： cells［J］. Environ Sci Pollut Res Int，2023，30（16）：
1024-1039 47780-47786
［13］SUN H，ZHANG T，ZHANG X，et al. Exosomal CCT6A se⁃ ［25］CHEN K，LI T，DIAO H，et al. SIRT7 knockdown pro⁃
creted by cancer⁃associated fibroblasts interacts with β⁃ motes gemcitabine sensitivity of pancreatic cancer cell
catenin to enhance chemoresistance and tumorigenesis in via upregulation of GLUT3 expression［J］. Cancer Lett，
gastric cancer［J］. Adv Sci，2025，12（38）：e06674 2024，598：217109
［14］LIU Y，CHEN J，MA L，et al. ZMIZ1 lactylation induces ［26］ZHANG K，ZHANG T，YANG Y，et al. N6 ⁃ methyl⁃
tamoxifen resistance in breast cancer through increasing adenosine⁃mediated LDHA induction potentiates chemo⁃
transcriptional activity of nanog to impact cell stemness resistance of colorectal cancer cells through metabolic re⁃
and cholesterol uptake［J］. Cell Biol Toxicol，2025，41 programming［J］. Theranostics，2022，12（10）：4802-
（1）：117 4817
［15］LI G，WANG D，ZHAI Y，et al. Glycometabolic reprogram⁃ ［27］JIANG X，GUO S，WANG S，et al. EIF4A3⁃induced cir⁃
ming⁃induced XRCC1 lactylation confers therapeutic re⁃ cARHGAP29 promotes aerobic glycolysis in docetaxel⁃re⁃
sistance in ALDH1A3 ⁃ overexpressing glioblastoma［J］. sistant prostate cancer through IGF2BP2/c ⁃ Myc/LDHA